3 A retrospective audit of mineralocorticoid receptor antagonist (mra) and device therapy following myocardial infarction (mi) complicated by left ventricular (lv) systolic dysfunction
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.